lobbying_activities: 832979
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 832979 | 49c5d474-94b7-4f35-adfe-0ab4ca49d6fc | Q3 | HEALTHFUTURES, LLC | 400359646 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2009 | third_quarter | MED | Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, comparative effectiveness research, DNA patents, workforce issues, influenza, standards development for diagnostics H.R.1699/S. 1220, Patient Access to Critical Lab Tests Act No bill #,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE | 30000 | 0 | 0 | 2009-10-16T15:40:10-04:00 |